These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 19181941)

  • 21. Benefits of tight blood pressure control to prevent diabetes complications were not sustained.
    O'Sullivan EP; Dinneen SF
    Evid Based Med; 2009 Feb; 14(1):9-10. PubMed ID: 19181942
    [No Abstract]   [Full Text] [Related]  

  • 22. Feasibility and acceptability of 'low-intensity mental health support via a telehealth-enabled network' for adults with type 1 and type 2 diabetes: the LISTEN pilot study.
    Holloway EE; Gray S; Halliday J; Harrap B; Hines C; Skinner TC; Speight J; Hendrieckx C
    Pilot Feasibility Stud; 2023 Jul; 9(1):133. PubMed ID: 37501203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expected Health Benefits of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Older Adults.
    Dadwani RS; Wan W; Skandari MR; Huang ES
    MDM Policy Pract; 2023; 8(2):23814683231187566. PubMed ID: 37492502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes.
    Bertoluci MC; Silva Júnior WS; Valente F; Araujo LR; Lyra R; de Castro JJ; Raposo JF; Miranda PAC; Boguszewski CL; Hohl A; Duarte R; Salles JEN; Silva-Nunes J; Dores J; Melo M; de Sá JR; Neves JS; Moreira RO; Malachias MVB; Lamounier RN; Malerbi DA; Calliari LE; Cardoso LM; Carvalho MR; Ferreira HJ; Nortadas R; Trujilho FR; Leitão CB; Simões JAR; Dos Reis MIN; Melo P; Marcelino M; Carvalho D
    Diabetol Metab Syndr; 2023 Jul; 15(1):160. PubMed ID: 37468901
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Huang H; Luo Y; Wang Q; Zhang Y; Li Z; He R; Chen X; Dong Z
    Nutrients; 2023 Apr; 15(9):. PubMed ID: 37432140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes control and cardiovascular risk, Part II: Intensive glucose control--UKPDS follow-up.
    Liebson PR
    Prev Cardiol; 2009; 12(1):51-8. PubMed ID: 19301692
    [No Abstract]   [Full Text] [Related]  

  • 27. The "legacy effect" associated with intensive glucose control in patients with type 2 diabetes.
    Mukherjee JT; Nesto RW
    Curr Diab Rep; 2009 Feb; 9(1):63-4. PubMed ID: 19192426
    [No Abstract]   [Full Text] [Related]  

  • 28. Preventing cardiovascular disease in type 2 diabetes: where do things stand with glycemic control? Part two.
    Chait A
    Curr Diab Rep; 2009 Feb; 9(1):9-10. PubMed ID: 19192418
    [No Abstract]   [Full Text] [Related]  

  • 29. Does intensive glycemic control for type 2 diabetes mellitus have long-term benefits for cardiovascular disease risk?
    Soldatos G; Cooper ME
    Nat Clin Pract Endocrinol Metab; 2009 Mar; 5(3):138-9. PubMed ID: 19190588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influencing factors of glycemic variability in hospitalized type 2 diabetes patients with insulin therapy: A Strobe-compliant article.
    Huang Y; Heng C; Wei J; Jing X; Wang X; Zhao G; Hou J; Liu Q; Jiao K
    Medicine (Baltimore); 2017 Sep; 96(36):e8021. PubMed ID: 28885369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of serum and urinal copper and zinc in Chinese northeast population with the prediabetes or diabetes with and without complications.
    Xu J; Zhou Q; Liu G; Tan Y; Cai L
    Oxid Med Cell Longev; 2013; 2013():635214. PubMed ID: 24175012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of high blood glucose fluctuation on endothelial function of type 2 diabetes mellitus rats and effects of Panax Quinquefolius Saponin of stem and leaf.
    Wang JS; Yin HJ; Guo CY; Huang Y; Xia CD; Liu Q
    Chin J Integr Med; 2013 Mar; 19(3):217-22. PubMed ID: 22610957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A better future for children with type 1 diabetes: Review of the conclusions from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study.
    Morales A
    J Ark Med Soc; 2009 Oct; 106(4):90-3. PubMed ID: 19813399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefits of early intensive glucose control to prevent diabetes complications were sustained for up to 10 years.
    O'Sullivan EP; Dinneen SF
    Evid Based Med; 2009 Feb; 14(1):9-10. PubMed ID: 19181941
    [No Abstract]   [Full Text] [Related]  

  • 36. Benefits of early intensive glucose control to prevent diabetes complications were sustained for up to 10 years.
    O'Sullivan EP; Dinneen SF
    ACP J Club; 2008 Dec; 149(6):4. PubMed ID: 19071870
    [No Abstract]   [Full Text] [Related]  

  • 37. Benefits of early intensive glucose control in preventing diabetes-related complications were sustained for up to 10 years.
    Sherifali D
    Evid Based Nurs; 2009 Jan; 12(1):14. PubMed ID: 19103832
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.